Myriad's post-SCOTUS analysis

Much attention has been given to the Myriad Genetics case recently argued before the Supreme Court, where Myriad Genetics claims a patent to not only a DNA test, but also to the isolated and refined DNA itself. Myriad claims this as an invention, while opponents argue that the genes are existing, natural substances.

Today, there's a guest post on the Patently-O blog by Benjamin Jackson, Senior Director of Legal Affairs at Myriad Genetics, where he makes his post-SCOTUS arguments.